NFKB1 and hepatocellular carcinoma: Based on the evidence that zinc finger protein A20 functioned as a negative regulator of NF-κB, overexpression of A20 and enhancing the activation of A20 could enhance HCC cells’ sensitivity to molecularly targeted agents via restricting the activation of the NF-κB pathway (6).